Fundamentals Data provided by Morningstar.Data provided by Morningstar.
52 Week Range
Avg. Volume (1 month)
as at 24 Feb 3:44pm
ASIC accuses ASX company of misleading COVID-19 claims
Why the Holista CollTech share price is climbing higher today
Share Market News
ASX stock of the day: This small-cap ASX wellness share jumped 6% today after it filed a global patent
These ASX shares are fighting the spread of coronavirus
The Holista Colltech share price soars 170% today
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
|Date||Announcement||Price Sensitive?||Time||No. of Pages||File Size|
Holista CollTech Ltd is a research-driven biotech company. Its operating segments include Supplements; Ovine Collagen; Infection Control Solutions; Food Ingredients; and Corporate. Supplements segment is involved in the manufacturing and wholesale distribution of dietary supplements. Ovine collagen segment is involved in the manufacturing and distribution of cosmetic grade collagen. Food ingredients segment is involved in the manufacturing and wholesale distribution of healthy food ingredients. Infection control segment is involved in the infection control solutions. The company generates a majority of its revenue from Supplements segment. Geographically, it generates a majority of its revenue from Malaysia.
|23 Nov 2023||$0.01||$0.00||0.00%||644,291||$0.01||$0.01||$0.01|
|22 Nov 2023||$0.01||$0.00||0.00%||75,000||$0.01||$0.01||$0.01|
|10 Nov 2023||$0.01||$0.00||0.00%||14,285||$0.01||$0.01||$0.01|
|09 Nov 2023||$0.01||$0.00||0.00%||100,000||$0.01||$0.01||$0.01|
|02 Nov 2023||$0.01||$0.00||0.00%||100,099||$0.01||$0.01||$0.01|
|01 Nov 2023||$0.01||$0.00||0.00%||100,000||$0.01||$0.01||$0.01|
|31 Oct 2023||$0.01||$0.00||0.00%||975,000||$0.01||$0.01||$0.01|
|Dr Rajendran (Rajen) Marnickavasagar (Manicka)||Managing DirectorChief Executive Officer||Jul 2009||
Dr Manicka began his career as an intern pharmacist at the Kuala Lumpur General Hospital from 1986 - 1987. In 1987 he spent a year as a community pharmacist. Over a period of 9 years, He worked for several pharmaceutical companies including Roche and CIBA Pharmaceuticals in various capacities starting as a medical representative, product manager and eventually as marketing manager. In 1995, he incorporated Total Health Concept. He has been a guest lecturer in alternative medicine at the University of Malaysia, the National University of Malaysia, and the International Medical University in Malaysia. He was also a health columnist for the Sunday Times. He is a member of the Malaysian Ministry of Health Standing Committee for Traditional Medicine and until March 2009 was on the board of Malaysian Herbal Corporation Sdn Bhd.
|Mr David Ross Deloub||Non-Executive ChairmanNon-Executive Director||Apr 2023||
Mr Deloub has 30 years experience in the finance and corporate sectors. David has held a number of executive positions including Chief Financial Officer at the ASX listed Neptune Marine Services and Executive Director at Patersons Capital Partners, a Perth based boutique advisory firm providing strategic and financial advice to ASX listed companies. David has considerable corporate finance, business development and financial market experience both in Australia the United States and Africa where he has held senior management positions at Alinta Energy Limited , Neptune Marine Services and Alcoa Inc in the US. David currently holds executive Board positions on the ASX listed Stonehorse Energy Limited and Avira Resources Limited. He has previously held a number of non-executive board positions including; Neptune Marine Services Limited, Merah Resources and Minquest Limited.
|Mrs Loren (Ann Jones) Anne King||Non-Executive Director||Jul 2021||
Mrs Loren King has worked in corporate finance and senior administration roles with ASX listed companies, stockbroking and corporate advisory services for the past 15 years. she has experience in dealing with all aspects of corporate governance and compliance.
|Mr Jay Richard Stephenson||Company Secretary||Sep 2021||
|Jay Richard Stephenson||Company Secretary||
|Galen Biomedical Inc||58,514,245||20.99%|
|BNP Paribas Nominees Pty Ltd||43,268,209||15.52%|
|818 Corporate Pty Ltd||13,196,169||4.73%|
|Ms Sarinderjit Kaur||9,675,785||3.47%|
|Citicorp Nominees Pty Limited||8,086,707||2.90%|
|Mr Robert Gemelli||7,915,016||2.84%|
|HSBC Custody Nominees (Australia) Limited(i)||7,829,102||2.81%|
|Mr Anthony Robert Ramage||7,000,000||2.51%|
|Fairview Holdings Pty Ltd||6,358,570||2.28%|
|Bnp Paribas Noms Pty Ltd||6,352,824||2.28%|
|123 Home Loans Pty Ltd||6,100,000||2.19%|
|Driscoll Future Pty Ltd||3,750,000||1.35%|
|Mr Himmat Singh||3,500,000||1.26%|
|Chandra Sekaran P Perumal||3,333,333||1.20%|
|Perpetual Capital Investments Pty Ltd||3,000,000||1.08%|
|Mr Peter Klimis||1,876,029||0.67%|
|HSBC Custody Nominees (Australia) Limited(ii)||1,799,994||0.65%|
|Neweconomy Com Au Nominees Pty Limited||1,709,938||0.61%|
|Neo Health Sdn Bhd||1,610,613||0.58%|
|Mr Kok Seng Chen||1,482,459||0.53%|